Guru Ownership Trend
Guru Analysis for Collegium Pharmaceutical, Inc. (COLL)
Collegium Pharmaceutical, Inc. (COLL), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $75.16 M.
Top institutional holders include Renaissance Technologies (RenTech) and Chuck Royce.
Institutional sentiment is currently Bullish. This is evidenced by a $1.15 M net inflow during the quarter.
Recent activity highlights Joel Greenblatt who increased their stake by 434.5%. Conversely, Jefferies Group reduced exposure by 45.1%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Collegium Pharmaceutical, Inc. (COLL)
Major holders include Renaissance Technologies (RenTech) ($48.59 M), Chuck Royce ($9.02 M), Cliff Asness ($4.47 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 2.08 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $1.15 M, with 4 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 0 fully exited COLL. The total reported sell value was $5.66 M.
Yes, 1 managers opened new positions in COLL, and 3 increased their existing holdings. The total reported buy value was $6.81 M.
